Sandoz Invests in New Biosimilar Manufacturing Facility
Janssen Seeks a Preliminary Injunction in BPCIA Ustekinumab Case Against Amgen
Denosumab Clinical Trial Updates
Mylan Voluntarily Recalls Additional Batch of Biosimilar Insulin Glargine Pens Due to Potential Missing Labels
Outlook Therapeutics to Revise Ophthalmic Bevacizumab BLA in Light of FDA Request
Celltrion to Enter U.S. Humira Biosimilar Market Following Patent Agreement with AbbVie
FDA to Hold Final Assessment of the Program for Enhanced Review Transparency and Communication in the Biosimilar User Fee Act
Biogen and Xbrane Enter into Worldwide Commercialization and License Agreement for Certolizumab Pegol Biosimilar
Alvotech and JAMP Pharma Receive Marketing Authorization for SIMLANDI in Canada
Subscribe: Subscribe via RSS
Blogs
Firm/Org